The latest announcement is out from Tsumura & Co ( (JP:4540) ).
Tsumura & Co. announced the intermediate results of its share repurchase program, where it acquired 206,400 shares at a cost of 908,870,200 yen. This move is part of a broader strategy approved by the board to repurchase up to 1,465,000 shares, with a maximum expenditure of 5 billion yen, aimed at enhancing shareholder value and optimizing capital structure.
More about Tsumura & Co
Tsumura & Co. operates in the pharmaceutical industry, focusing on the production and distribution of traditional Japanese Kampo medicines. The company is listed on the Tokyo Stock Exchange Prime Market and is known for its commitment to integrating traditional herbal remedies with modern pharmaceutical practices.
YTD Price Performance: -4.71%
Technical Sentiment Signal: Sell
Current Market Cap: $2.2B
Learn more about 4540 stock on TipRanks’ Stock Analysis page.